Siamab Therapeutics
Newton, US
Biotech
Founders & leadership
JB
Jeffrey BehrensExecutive Officer, Director
RM
Robert MashalDirector
BC
Brad CurleyDirector
GP
Gary PforzheimerDirector
PK
Peter KroonDirector
Reported raises · per SEC filings
Form D private placements$664.5KraisedNov 2018 · 21 investors · Biotechnology
Rule 506(b)$3.2MraisedMar 2016 · 64 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.